Your browser doesn't support javascript.
loading
Retrospective Study on the Efficacy and Safety of Pyrotinib-Based Therapy for HER2-Positive Nonbreast Advanced Solid Tumors.
Wang, Jianzheng; Zhang, Baiwen; Cheng, Xiaojiao; Li, Qingli; Lv, Huifang; Nie, Caiyun; Chen, Beibei; Xu, Weifeng; Zhao, Jing; He, Yunduan; Tu, Shuiping; Chen, Xiaobing.
Afiliação
  • Wang J; Department of Medical Oncology, Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou Henan Province 450008, China.
  • Zhang B; Department of Oncology, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai 200127, China.
  • Cheng X; Department of Oncology, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai 200127, China.
  • Li Q; Department of Oncology, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai 200127, China.
  • Lv H; Department of Medical Oncology, Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou Henan Province 450008, China.
  • Nie C; Department of Medical Oncology, Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou Henan Province 450008, China.
  • Chen B; Department of Medical Oncology, Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou Henan Province 450008, China.
  • Xu W; Department of Medical Oncology, Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou Henan Province 450008, China.
  • Zhao J; Department of Medical Oncology, Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou Henan Province 450008, China.
  • He Y; Department of Medical Oncology, Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou Henan Province 450008, China.
  • Tu S; Department of Oncology, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai 200127, China.
  • Chen X; Department of Medical Oncology, Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou Henan Province 450008, China.
J Oncol ; 2022: 4233782, 2022.
Article em En | MEDLINE | ID: mdl-35368895

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article